Question 1

Colloids & amphiphiles – In aqueous solution, how are micelles of fatty acids oriented with respect to water exposure and core packing?

Accepted Answer

Introduction / Context: Micelles are supramolecular aggregates formed by amphiphiles, such as fatty acids, when dispersed in water above a critical micelle concentration. Understanding how hydrophilic and hydrophobic moieties orient relative to the aqueous environment is fundamental in biochemistry, membrane science, and drug delivery. Given Data / Assumptions: Fatty acids possess a polar, ionizable carboxylate head and a nonpolar hydrocarbon tail. Water is a polar solvent that favors interactions with charged/polar groups. Micelles minimize the free energy associated with exposing hydrophobic surfaces to water. Concept / Approach: To reduce the hydrophobic effect penalty, amphiphiles orient so that polar head groups remain solvated at the micelle surface, while hydrophobic tails are sequestered in an apolar core. Fatty acid carboxylate groups (hydrophilic heads) hydrogen-bond/ionically interact with water; the alkyl chains cluster internally, driving micelle formation. Step-by-Step Solution: Consider amphiphile polarity: head (hydrophilic) vs tail (hydrophobic).Predict orientation in water: heads outside, tails inside.Relate to thermodynamics: hydrophobic effect reduces ordered water cages, lowering free energy.Therefore, statements that say “heads face water, tails inside” are correct. Verification / Alternative check: Scattering and spectroscopic studies show micellar radii with hydrated surfaces and hydrophobic cores; detergents demonstrate similar orientations, enabling solubilization of membrane proteins. Why Other Options Are Wrong: Hydrocarbon chains facing solvent contradicts the hydrophobic effect. Equal exposure has no basis; micelles have distinct core–shell architecture. Common Pitfalls: Confusing micelles (spherical, tails in) with bilayers (two leaflets) or reverse micelles (nonpolar solvent, reversed orientation). Final Answer: Both (a) and (b) describe the same correct orientation

Question 2

Lipoprotein metabolism – Very-low-density lipoproteins (VLDLs) are synthesized predominantly in which organ?

Accepted Answer

Introduction / Context: Lipoproteins transport lipids through the aqueous bloodstream. Each class has a distinct site of assembly and apolipoprotein composition. VLDLs carry endogenously synthesized triacylglycerols from the liver to peripheral tissues. Identifying their origin is core to dyslipidemia and cardiovascular biochemistry. Given Data / Assumptions: VLDLs contain ApoB-100, ApoE, and ApoCs. Chylomicrons are of intestinal origin and carry dietary lipids. The liver exports endogenous triacylglycerols and cholesterol via VLDL. Concept / Approach: Hepatocytes assemble VLDL particles in the endoplasmic reticulum, requiring microsomal triglyceride transfer protein for ApoB-100 lipidation. Secreted VLDL matures in plasma by acquiring ApoC-II and ApoE from HDL and is progressively lipolyzed by lipoprotein lipase, yielding IDL and LDL. Step-by-Step Solution: Differentiate exogenous (chylomicron) vs endogenous (VLDL) pathways.Identify ApoB isoform: ApoB-100 indicates hepatic origin.Conclude that VLDL is synthesized in the liver. Verification / Alternative check: Clinical markers link hepatic overproduction of VLDL with hypertriglyceridemia; genetic defects in MTP impair VLDL secretion, causing abetalipoproteinemia. Why Other Options Are Wrong: Intestine produces chylomicrons (ApoB-48), not VLDL. Blood is a transport medium, not a site of synthesis. Pancreas/adipose do not assemble VLDL particles. Common Pitfalls: Confusing chylomicron and VLDL origins because both carry triacylglycerols. Final Answer: Liver (hepatocytes)

Question 3

Metabolic limitation – Why can animals not convert even-chain fatty acids into net glucose via standard central metabolic pathways?

Accepted Answer

Introduction / Context: Textbook biochemistry emphasizes that animals cannot generate net glucose from even-chain fatty acids. The biochemical reason rests on carbon accounting and reaction irreversibility. This question asks you to identify the key metabolic block that prevents acetyl-CoA carbons from reappearing as glucose in animals. Given Data / Assumptions: Even-chain fatty acids degrade by beta-oxidation to acetyl-CoA units. Pyruvate dehydrogenase converts pyruvate to acetyl-CoA irreversibly. Animals do not have the glyoxylate cycle (isocitrate lyase and malate synthase), which would bypass CO2-releasing steps. Concept / Approach: In the tricarboxylic acid cycle, acetyl-CoA carbons enter and equivalent carbons leave as CO2 over turns of the cycle, yielding no net gain of oxaloacetate for gluconeogenesis. Because pyruvate dehydrogenase is irreversible, acetyl-CoA cannot be converted upstream to pyruvate or oxaloacetate. Plants, fungi, and bacteria use the glyoxylate cycle to conserve carbons for gluconeogenesis, but animals lack this shunt. Step-by-Step Solution: Start with even-chain fatty acids → beta-oxidation → acetyl-CoA.Note the irreversible step: pyruvate dehydrogenase is one-way (pyruvate → acetyl-CoA).In TCA, acetyl-CoA carbons are lost as CO2, yielding no net oxaloacetate.Without a glyoxylate cycle, there is no bypass to conserve carbons for glucose. Verification / Alternative check: Tracer studies show acetyl-CoA carbons do not accumulate in gluconeogenic intermediates in animals; odd-chain fatty acids can contribute via propionyl-CoA → succinyl-CoA → oxaloacetate, highlighting the exception that proves the rule. Why Other Options Are Wrong: Lack of pyruvate carboxylase: false; this enzyme is present and essential for gluconeogenesis. Beta-oxidation produces acetyl-CoA, not lactate. Glycolysis is active in liver; the issue is directionality and carbon balance, not pathway absence. Malate–aspartate shuttle exists in animals; it transfers reducing equivalents. Common Pitfalls: Forgetting about the glyoxylate cycle in microbes/plants and assuming acetyl-CoA can be “pulled back” to pyruvate; the PDH step blocks this. Final Answer: Acetyl-CoA cannot be converted back to pyruvate in animals (pyruvate dehydrogenase step is irreversible)

Question 4

Digestion of dietary lipids – In the human small intestine, which enzyme is primarily responsible for hydrolyzing triacylglycerols from food?

Accepted Answer

Introduction / Context: Efficient digestion and absorption of dietary fats require enzymatic hydrolysis of triacylglycerols to free fatty acids and monoacylglycerols. The key catalyst in the lumen of the small intestine is pancreatic lipase, assisted by colipase and bile salts. This question assesses recognition of the principal enzyme and location. Given Data / Assumptions: Bile acids emulsify fats, increasing surface area for enzymes. Pancreatic lipase is secreted into the duodenum and jejunum. Hydrolysis products form mixed micelles for uptake by enterocytes. Concept / Approach: Pancreatic triacylglycerol lipase cleaves ester bonds at the sn-1 and sn-3 positions, yielding two free fatty acids and 2-monoacylglycerol. Colipase anchors lipase to the lipid–water interface in the presence of bile salts, ensuring high activity in the intestinal milieu. Other listed enzymes are not lipases and do not hydrolyze dietary triacylglycerols. Step-by-Step Solution: Emulsification by bile salts creates accessible lipid droplets.Pancreatic lipase + colipase bind to droplet surfaces.Ester bonds at sn-1 and sn-3 are hydrolyzed → fatty acids + 2-MAG.Absorption: products enter enterocytes via micelles; re-esterified into TAGs for chylomicron assembly. Verification / Alternative check: Pancreatic insufficiency reduces fat absorption and causes steatorrhea; enzyme replacement therapy with lipase improves digestion, confirming its pivotal role. Why Other Options Are Wrong: Adenylate cyclase and protein kinase A are signaling enzymes. Amylase digests starch; pepsin digests proteins in the stomach. Common Pitfalls: Confusing “gastric lipase” (minor contributor) with the major intestinal enzyme “pancreatic lipase.” Final Answer: Triacylglycerol lipase secreted by the pancreas (pancreatic lipase)

Question 5

Cardiovascular pathology – Atherosclerosis most directly increases the risk of which blood-related event?

Accepted Answer

Introduction / Context: Atherosclerosis is characterized by lipid-rich plaques within arterial walls. Plaque instability and rupture expose prothrombotic material to the bloodstream, precipitating acute thrombus formation. Recognizing clotting as the key immediate complication clarifies why atherosclerosis underlies myocardial infarction and ischemic stroke. Given Data / Assumptions: Atherosclerotic plaques can become inflamed and rupture. Exposure of tissue factor and subendothelial matrix triggers the coagulation cascade and platelet aggregation. Occlusive thrombi reduce or stop downstream blood flow. Concept / Approach: The pathogenic sequence involves endothelial dysfunction, plaque growth, and potential rupture. Thrombus formation at the rupture site may partially or completely occlude the artery, causing acute ischemia. This is a clotting phenomenon, not “blood thinning” or generalized viscosity changes. Step-by-Step Solution: Plaque forms and destabilizes due to inflammation and lipid core.Rupture exposes thrombogenic material to circulating blood.Platelet adhesion/activation and coagulation cascade create a fibrin-rich thrombus.Vessel lumen narrows or occludes → ischemia/infarction. Verification / Alternative check: Clinical imaging and pathology show fresh thrombi over disrupted plaques in acute coronary syndromes; antiplatelet and anticoagulant therapies reduce event rates. Why Other Options Are Wrong: Blood thinning: opposite effect; atherothrombosis promotes clotting. Uniform “thickening” of blood is not a principal consequence of plaques. Hemolysis is not a hallmark consequence of atherosclerotic lesions. Common Pitfalls: Equating chronic plaque stenosis with viscosity changes; the acute risk is thrombus formation after plaque rupture. Final Answer: Thrombotic blood clot formation at sites of plaque rupture

Question 6

Fatty acid structures – Arachidonic acid (arachidonate) contains 20 carbon atoms with how many double bonds?

Accepted Answer

Introduction / Context: Arachidonic acid is a polyunsaturated omega-6 fatty acid central to eicosanoid biosynthesis (prostaglandins, thromboxanes, leukotrienes). Recognizing its carbon length and degree of unsaturation is fundamental in lipid biochemistry and physiology. Given Data / Assumptions: Molecular shorthand for arachidonate is 20:4 (n−6). Double bond count determines fluidity and substrate specificity for oxygenases (COX, LOX). Eicosanoid signaling affects inflammation, thrombosis, and vascular tone. Concept / Approach: The notation 20:4 indicates 20 carbons and 4 cis double bonds. In mammalian membranes, these are typically at Δ5,8,11,14 positions (counting from the carboxyl end). This structural feature underlies its conversion to potent lipid mediators upon phospholipase A2 activation. Step-by-Step Solution: Recall notation: 20:4 → 20 carbons, 4 double bonds.Map double bonds to classical positions (5,8,11,14).Identify it as an omega-6 PUFA (last double bond 6 carbons from methyl end).Select “4 double bonds.” Verification / Alternative check: Biochemical catalogs and lipidomic analyses consistently annotate arachidonic acid as 20:4 (n−6), confirming the four double bonds. Why Other Options Are Wrong: 2 or 3 double bonds: would correspond to other fatty acids (e.g., linoleic acid is 18:2). 8 double bonds or 0: not consistent with arachidonate’s known structure. Common Pitfalls: Confusing arachidonic (20:4) with arachidic acid (20:0), the saturated analog. Final Answer: 4 double bonds

Question 7

Lipoprotein classes – How many major types of lipoproteins are recognized in human plasma based on density and composition?

Accepted Answer

Introduction / Context: Lipoproteins package hydrophobic lipids for transport in blood. Classifying them by density and apolipoprotein content is essential for understanding lipid metabolism and cardiovascular risk profiles. Given Data / Assumptions: The classical plasma lipoprotein classes are chylomicrons, VLDL, IDL, LDL, and HDL. Each class differs in lipid/protein ratio, size, and metabolic fate. Clinical assays often report LDL and HDL cholesterol; VLDL and IDL are also clinically relevant. Concept / Approach: Counting the major classes yields five. While subclasses exist (e.g., HDL2 vs HDL3; small dense LDL), the principal categories used in textbooks and diagnostics remain five. Step-by-Step Solution: List the five classes explicitly.Recognize that subclasses do not change the number of major classes.Select “5.” Verification / Alternative check: Ultracentrifugation and electrophoretic methods reproducibly resolve these five major classes; clinical guidelines reference them. Why Other Options Are Wrong: 2, 4: underestimate; 6 or 8: would count subclasses or nonstandard categories. Common Pitfalls: Confusing subclasses with major classes, leading to overcounting. Final Answer: 5

Question 8

Apolipoproteins – What is the principal protein component of high-density lipoprotein (HDL) particles?

Accepted Answer

Introduction / Context: HDL mediates reverse cholesterol transport and exerts anti-atherogenic effects. Its functional properties are closely tied to its apolipoprotein composition, particularly ApoA-I, which activates lecithin:cholesterol acyltransferase (LCAT) and scaffolds HDL structure. Given Data / Assumptions: HDL is protein-rich relative to other lipoproteins. ApoA-I is the dominant structural apolipoprotein in HDL. ApoC and ApoE are exchangeable apolipoproteins but not the principal scaffold of HDL. Concept / Approach: ApoA-I binds phospholipids to form nascent HDL, activates LCAT to esterify cholesterol, and promotes cholesterol efflux from cells via ABCA1/ABCG1 transporters. Therefore, ApoA-I is the defining major protein of HDL. Step-by-Step Solution: Identify HDL's scaffold protein: ApoA-I.Differentiate accessory apolipoproteins (ApoC-I, ApoE) that HDL can carry transiently.Exclude ApoB-100, which is characteristic of VLDL/LDL. Verification / Alternative check: Proteomic analyses show ApoA-I as the predominant HDL apolipoprotein; genetic deficiency of ApoA-I leads to markedly reduced HDL levels. Why Other Options Are Wrong: ApoC-I and ApoE: present but not the principal HDL scaffold. ApoB-100: signature of VLDL/IDL/LDL, not HDL. “None of these” is incorrect because ApoA-I is correct. Common Pitfalls: Assuming ApoE is the main HDL apolipoprotein because of its role in receptor binding; it is important but not the major constituent. Final Answer: Apolipoprotein A-I

Question 9

Regulation of lipid biosynthesis – Identify the key rate-limiting enzyme that controls fatty acid synthesis in animals.

Accepted Answer

Introduction / Context: Fatty acid synthesis requires coordinated regulation to balance energy storage and expenditure. The committed, rate-limiting step is catalyzed by acetyl-CoA carboxylase (ACC), which converts acetyl-CoA to malonyl-CoA. Recognizing ACC's central regulatory position is crucial for understanding metabolic control and pharmacologic targets. Given Data / Assumptions: ACC activity determines malonyl-CoA levels, the 2-carbon donor for fatty acid synthase. Malonyl-CoA also inhibits fatty acid oxidation by suppressing CPT I. ACC is regulated by phosphorylation/dephosphorylation and allosteric effectors. Concept / Approach: ACC is activated by citrate (polymerization) and dephosphorylation, and inhibited by phosphorylation via AMPK and by long-chain acyl-CoAs. Thus, while AMPK and phosphatases regulate ACC, they are not the rate-limiting enzyme themselves. Selecting ACC identifies the enzyme that directly sets the pace of fatty acid synthesis. Step-by-Step Solution: Recall the pathway: acetyl-CoA → malonyl-CoA (ACC) → elongation by fatty acid synthase.Recognize malonyl-CoA as both substrate for synthesis and inhibitor of oxidation.Identify ACC as the committed, rate-limiting step under hormonal and nutrient control.Select ACC among regulators and unrelated enzymes. Verification / Alternative check: Genetic and pharmacological manipulation of ACC levels/activity alters lipogenesis rates and malonyl-CoA concentrations; AMPK activators reduce lipogenesis by inhibiting ACC. Why Other Options Are Wrong: AMPK and phosphatases regulate ACC but are not the committed step. CPT I is in fatty acid oxidation, not synthesis. “None of these” is incorrect because ACC is correct. Common Pitfalls: Confusing upstream regulators (AMPK) with the rate-limiting enzyme itself. Final Answer: Acetyl-CoA carboxylase (ACC)

Question 10

Fatty acid catabolism in eukaryotes — site of β-oxidation  In cellular metabolism of eukaryotes, the stepwise breakdown of long-chain fatty acids by β-oxidation primarily occurs in which compartment?

Accepted Answer

Introduction / Context: Fatty acid catabolism supplies acetyl CoA, NADH, and FADH2 to fuel ATP production. In eukaryotic cells, the canonical pathway for degrading most long chain fatty acids is β oxidation. Correctly identifying the subcellular location of this pathway is critical for understanding metabolic integration and disease states such as disorders of fatty acid oxidation. Given Data / Assumptions: Question refers to eukaryotes (animals/humans). Process is fatty acid breakdown via β oxidation. Consider common long chain fatty acids after activation and transport. Concept / Approach: In eukaryotes, long chain acyl CoA esters are transported into mitochondria via the carnitine shuttle (CPT I, carnitine acylcarnitine translocase, CPT II). Once inside, the β oxidation spiral proceeds in the mitochondrial matrix, yielding acetyl CoA and reduced cofactors that feed the TCA cycle and the respiratory chain. Very long chain fatty acids can undergo initial shortening in peroxisomes, but the bulk energy yielding β oxidation for common chains occurs in the mitochondrial matrix. Step-by-Step Solution: Activate fatty acid: FA + CoA + ATP → acyl CoA (in cytosol/outer mitochondrial membrane).Transport: acyl group transferred to carnitine (CPT I), shuttled across inner membrane, then back to CoA (CPT II).Mitochondrial matrix reactions: dehydrogenation → hydration → dehydrogenation → thiolysis.Outputs: acetyl CoA enters TCA cycle; FADH2 and NADH power oxidative phosphorylation. Verification / Alternative check: Biochemical fractionation localizes β oxidation enzymes (acyl CoA dehydrogenases, enoyl CoA hydratase, hydroxyacyl CoA dehydrogenase, thiolase) to the mitochondrial matrix. Genetic defects in CPT or matrix enzymes produce characteristic acylcarnitine profiles, confirming compartmentalization. Why Other Options Are Wrong: Cell membrane and ER are not the primary sites of β oxidation; ER handles lipid synthesis and desaturation. Cytosol hosts fatty acid synthesis, not mitochondrial β oxidation. Periplasmic space applies to prokaryotes, not eukaryotes. Common Pitfalls: Confusing peroxisomal very long chain oxidation with the main ATP generating β oxidation or mixing up synthesis (cytosol) with breakdown (mitochondria). Final Answer: Mitochondrial matrix

Question 11

Sites of HDL (high-density lipoprotein) biogenesis  In human lipoprotein metabolism, where are nascent HDLs synthesized before they mature in plasma?

Accepted Answer

Introduction / Context: High density lipoproteins (HDLs) mediate reverse cholesterol transport, shuttling excess cholesterol from peripheral tissues to the liver. Understanding where HDLs originate helps explain clinical biomarkers such as HDL cholesterol and the actions of apolipoproteins like ApoA I. Given Data / Assumptions: HDL particles begin as small, discoidal, protein rich particles. ApoA I is the signature apolipoprotein of HDL. Plasma enzymes (LCAT) and transporters (ABCA1, ABCG1) remodel HDLs after secretion. Concept / Approach: Nascent HDLs are synthesized and secreted primarily by hepatocytes (liver) and enterocytes (intestine). These tissues produce ApoA I and other components. Once in plasma, interactions with ABCA1 on peripheral cells load free cholesterol and phospholipid onto ApoA I to form discoidal HDL, which is then esterified by LCAT into cholesteryl esters, generating spherical HDL that can exchange lipids via CETP and deliver cholesterol to the liver via SR B1. Step-by-Step Solution: Identify tissue sources: hepatocytes and intestinal enterocytes synthesize ApoA I and pre β HDL.Secretion to plasma: nascent particles enter circulation.Plasma maturation: ABCA1 lipidates ApoA I; LCAT converts cholesterol to cholesteryl esters; HDLs become spherical.Function: mature HDLs deliver cholesterol to liver for excretion or recycling. Verification / Alternative check: Tracer studies and gene expression data show high ApoA I production in liver and intestine; genetic defects in ABCA1 cause Tangier disease with near absence of HDL, supporting the biogenesis pathway. Why Other Options Are Wrong: Blood is the conduit, not the site of synthesis; particles are cell derived. Pancreas and kidney are not primary HDL synthetic organs. Adipose tissue contributes lipids but does not synthesize nascent HDL as the main source. Common Pitfalls: Assuming HDL forms spontaneously in plasma without cellular origin or confusing HDL origin with chylomicron origin (intestine only). Final Answer: Liver and intestine (both tissues)

Question 12

Physical properties of triacylglycerols (TAGs)  In aqueous systems relevant to human biology, triacylglycerols are best described as:

Accepted Answer

Introduction / Context: Triacylglycerols (TAGs) are the predominant storage lipids in animals and plants. Their solubility characteristics determine how they are digested, transported, and stored. Understanding that TAGs are hydrophobic neutral lipids explains the need for emulsification and lipoprotein transport systems. Given Data / Assumptions: TAGs consist of glycerol esterified to three fatty acids. No charged headgroup is present at physiological pH. Biological fluids are aqueous and require specialized carriers for hydrophobes. Concept / Approach: The extensive hydrocarbon chains of fatty acyl groups confer strong hydrophobicity, while the ester linkages are neutral. Consequently, TAGs are effectively insoluble in water and segregate into oil droplets. Digestion in the intestine relies on bile salts that emulsify TAGs, and lipoproteins (e.g., chylomicrons, VLDL) transport them through blood and lymph. Step-by-Step Solution: Recognize chemical structure: glycerol triesters of long chain fatty acids.Infer net polarity: minimal; no ionic or strongly polar headgroup.Predict solubility: insoluble in water, soluble in nonpolar solvents.Relate to physiology: need for emulsifiers and lipoprotein packaging. Verification / Alternative check: Experimental partitioning shows TAGs have negligible aqueous solubility; droplet formation and creamy layers in un-emulsified systems visually demonstrate hydrophobicity. Why Other Options Are Wrong: Water solubility (Options B and D) contradicts chemical nature; partial solubility (C) is incorrect because the glycerol core is masked by nonpolar chains. Option E describes amphipathic detergents (e.g., bile salts), not neutral TAGs. Common Pitfalls: Confusing TAGs with phospholipids; the latter have charged headgroups and amphipathic behavior. Final Answer: Insoluble in water (hydrophobic neutral lipids)

Question 13

Meaning of familial hypercholesterolemia in lipid metabolism  In human genetics and metabolism, familial hypercholesterolemia (a form of cholesterolemia) most commonly results from:

Accepted Answer

Introduction / Context: Familial hypercholesterolemia (FH) is a classic autosomal disorder causing markedly elevated LDL cholesterol and premature atherosclerosis. The prototypical molecular lesion involves the LDL receptor pathway. Recognizing this mechanism is essential for interpreting lipid profiles and therapy choices (statins, PCSK9 inhibitors). Given Data / Assumptions: FH leads to high plasma LDL cholesterol from birth. LDL receptor (LDLR) mediates endocytosis of LDL particles via ApoB100. Alternative, rarer causes exist (ApoB100 mutations, PCSK9 gain of function), but LDLR deficiency is most common. Concept / Approach: Defective or absent LDL receptors reduce hepatic clearance of LDL, increasing circulating LDL particle concentration. Elevated LDL promotes cholesterol deposition in tendons (xanthomas) and arteries. Targeted therapies upregulate LDLR or reduce LDL production to mitigate risk. Step-by-Step Solution: Identify the principal pathway clearing LDL: LDLR mediated endocytosis.Recognize that receptor defects elevate LDL cholesterol levels.Link phenotype (xanthomas, early CAD) to impaired LDL clearance.Select the option describing lack of functional LDL receptors. Verification / Alternative check: Cellular studies show reduced LDL uptake in FH fibroblasts; genetic testing frequently reveals LDLR mutations. PCSK9 gain of function also reduces receptor levels, reinforcing LDLR centrality. Why Other Options Are Wrong: HDL receptor (SR B1) defects are not the canonical cause of FH. Dietary sensitivity alone cannot explain severe, lifelong hypercholesterolemia. ApoB48 absence pertains to chylomicron assembly, not the classic FH phenotype. Common Pitfalls: Equating general high cholesterol with FH or assuming diet alone causes extreme LDL elevations found in FH. Final Answer: Lack of functional LDL receptors leading to impaired LDL clearance

Question 14

Lowest caloric value among listed lipids or fat substitutes  For human nutrition, which listed substance effectively provides the lowest usable energy (kcal) per gram?

Accepted Answer

Introduction / Context: Caloric yield depends on digestion, absorption, and metabolic oxidation. Most edible fats deliver about 9 kcal per gram. Olestra is a sucrose polyester engineered to be non hydrolyzable by human lipases, passing through the gut largely unabsorbed and thereby contributing essentially no metabolizable energy. Given Data / Assumptions: Standard dietary fats (olive oil, margarine, MCT oil) are triacylglycerol based. Olestra’s ester linkages are sterically shielded from pancreatic lipase. Cardiolipin is a membrane lipid, not a typical human food source. Concept / Approach: Compare digestibility and absorption. Traditional fats are efficiently digested into fatty acids and monoacylglycerols and absorbed as chylomicrons, yielding high caloric value. By contrast, olestra is excreted intact, so its effective caloric contribution is approximately zero, making it the lowest energy value among the options for human nutrition. Step-by-Step Solution: Identify metabolizable vs non metabolizable lipids.Note that olestra resists enzymatic hydrolysis → minimal absorption.Conclude near zero caloric yield for olestra compared with ~9 kcal/g for edible fats.Select olestra as lowest energy value. Verification / Alternative check: Human studies show intake of olestra does not raise postprandial triglycerides and contributes negligible energy; labels often list zero calories per serving. Why Other Options Are Wrong: Olive oil, margarine, and MCT oil are digestible energy dense fats. Cardiolipin is not consumed as a dietary fat and, if ingested as part of food, would still be metabolizable as phospholipids. Common Pitfalls: Confusing “low fat” with “zero calories,” or assuming all lipids yield the same energy regardless of digestibility. Final Answer: Olestra (a non-absorbable fat substitute)

Question 15

Structure of palmitate (palmitic acid, C16)  Palmitate is a 16-carbon fatty acid that is typically:

Accepted Answer

Introduction / Context: Naming conventions for fatty acids encode chain length and unsaturation. Palmitate (palmitic acid) is one of the most abundant saturated fatty acids in animals and plants. Correctly identifying its double bond count is fundamental in lipid chemistry and nutrition science. Given Data / Assumptions: Palmitate is denoted 16:0 in shorthand. Chain length = 16 carbons. Unsaturation number = 0 when saturated. Concept / Approach: Shorthand X:Y indicates carbon number X and number of double bonds Y. For palmitate, 16:0 means a saturated C16 fatty acid with zero double bonds. It is a major product of de novo fatty acid synthesis via fatty acid synthase, which commonly terminates at palmitate before elongation/desaturation steps modify it further. Step-by-Step Solution: Interpret notation: 16:0 → sixteen carbons, zero double bonds.Recall biosynthesis: acetyl CoA + malonyl CoA units → palmitate 16:0.Recognize that desaturases can convert 16:0 to 16:1, but native palmitate is saturated.Choose the option stating 0 double bonds. Verification / Alternative check: Databases and textbooks consistently list palmitic acid as C16:0; common palmitoleic acid is C16:1 Δ9, a different molecule. Why Other Options Are Wrong: Options B–D describe unsaturated variants, not palmitate. Option E confuses geometry and saturation; palmitate is not polyunsaturated and has no double bonds at all. Common Pitfalls: Confusing palmitate (C16:0) with palmitoleate (C16:1) or equating chain length with degree of unsaturation. Final Answer: Fully saturated with 0 double bonds

Question 16

Physiological conditions favoring fatty acid synthesis  Lipogenesis (de novo fatty acid synthesis) in liver and adipose tissue is most active when:

Accepted Answer

Introduction / Context: Fatty acid synthesis is an anabolic pathway that stores excess energy as triacylglycerol. Hormonal and nutrient cues switch the liver and adipose tissue between catabolic (fasted) and anabolic (fed) modes. Understanding these cues clarifies how diet influences lipid metabolism and body composition. Given Data / Assumptions: Fed state: high insulin, low glucagon; abundant glucose. Excess carbohydrate provides carbon skeletons via citrate export. Sufficient ATP and NADPH are required for synthesis. Concept / Approach: In the fed state, glycolysis and the TCA cycle generate citrate that exits mitochondria. ATP citrate lyase produces cytosolic acetyl CoA, which is carboxylated by ACC to malonyl CoA. Fatty acid synthase uses malonyl CoA and NADPH (from pentose phosphate pathway and malic enzyme) to build palmitate. Insulin activates ACC and induces lipogenic gene expression (SREBP 1c), aligning carbon and energy availability with lipogenesis. Step-by-Step Solution: Identify hormonal milieu: high insulin/low glucagon → activates ACC/FAS.Ensure substrates and reducing power: acetyl CoA, malonyl CoA, NADPH, ATP abundant.Recognize malonyl CoA inhibits CPT1, decreasing β oxidation and favoring synthesis.Select the condition: carbohydrate and energy plentiful. Verification / Alternative check: Postprandial tracer studies show increased lipogenesis; fasting or high glucagon suppresses it and promotes fatty acid oxidation and ketogenesis. Why Other Options Are Wrong: Energy scarcity inhibits synthesis despite fatty acid abundance. High carbohydrate without ATP cannot sustain lipogenesis. Prolonged fasting elevates glucagon, which turns off ACC and lipogenesis. Common Pitfalls: Assuming substrate abundance alone is enough; hormonal regulation and ATP/NADPH availability are also required. Final Answer: Carbohydrate and energy supplies are plentiful (fed state)

Question 17

Origin of chylomicrons in lipoprotein metabolism  Chylomicrons, the lipoproteins that transport dietary triacylglycerols, are synthesized in which tissue?

Accepted Answer

Introduction / Context: Chylomicrons ferry dietary lipids from the intestine through lymph into the bloodstream. Correctly assigning their site of assembly is fundamental for understanding postprandial lipid metabolism and disorders such as abetalipoproteinemia and familial chylomicronemia syndrome. Given Data / Assumptions: Dietary fats are digested to fatty acids and monoacylglycerols. Enterocytes re esterify these into triacylglycerols. Lipoprotein assembly requires apolipoprotein B48 and microsomal triglyceride transfer protein (MTP). Concept / Approach: Within enterocytes, TAGs, cholesterol esters, and phospholipids are packaged with ApoB48 to form nascent chylomicrons. These particles enter lacteals, travel via lymph to the thoracic duct, and then enter the bloodstream. In capillaries, lipoprotein lipase hydrolyzes TAGs, delivering fatty acids to tissues; remnants are cleared by the liver. Step-by-Step Solution: Localization: small intestinal mucosa (enterocytes) assemble chylomicrons.Packaging: lipids + ApoB48 + MTP → nascent chylomicron.Transport: lymph → venous blood; maturation with ApoCII and ApoE from HDL.Clearance: LPL action and hepatic remnant uptake. Verification / Alternative check: Genetic absence of ApoB48 or MTP blocks chylomicron formation, causing fat malabsorption and low postprandial triglycerides, confirming intestinal origin. Why Other Options Are Wrong: Liver synthesizes VLDL, not chylomicrons. Plasma is a transport medium, not a synthetic site. Pancreas produces lipases, not lipoproteins; adipocytes store fat but do not assemble chylomicrons. Common Pitfalls: Confusing chylomicrons (dietary origin) with VLDL (endogenous TAGs) or assuming all lipoproteins come from the liver. Final Answer: Intestinal enterocytes (small intestine)

Question 18

Stoichiometry of phosphatidylserine (PS) formation  During the biosynthesis of phosphatidylserine in mammals, how many water (H2O) molecules are directly consumed by the head group formation reaction?

Accepted Answer

Introduction / Context: Phosphatidylserine (PS) is a major anionic phospholipid in eukaryotic membranes. In mammals, PS is primarily formed by a base exchange reaction rather than by the CDP diacylglycerol pathway used in many bacteria. Knowing the reaction chemistry clarifies whether water is consumed during PS head group formation. Given Data / Assumptions: Mammalian PS synthase 1 and 2 (PSS1, PSS2) catalyze base exchange on existing phospholipids. Substrates are phosphatidylcholine (PC) or phosphatidylethanolamine (PE) plus serine. Reaction swaps the head group; no hydrolysis by water is required for the exchange itself. Concept / Approach: In the base exchange mechanism, serine displaces choline (from PC) or ethanolamine (from PE) to generate PS and release the corresponding amine. The reaction proceeds without direct consumption of water. In bacterial pathways, PS can form from CDP diacylglycerol + serine → PS + CMP, again not requiring water for the bond forming step. Therefore, the number of water molecules consumed for PS formation is zero in the canonical reaction. Step-by-Step Solution: Identify mammalian route: PC/PE + serine → PS + choline/ethanolamine (base exchange).Inspect stoichiometry: no H2O appears as a reactant in the head group exchange.Alternative bacterial route: CDP DG + serine → PS + CMP; again, no H2O consumed.Conclude that H2O consumed = 0 for PS formation. Verification / Alternative check: Enzymology of PSS1/PSS2 shows direct displacement; water involvement is not part of the net reaction. PS decarboxylation to PE (mitochondrial PSD) releases CO2, not water. Why Other Options Are Wrong: Options 1, 2, 3, and 4 introduce water where it is not required by the reaction mechanism; they confuse hydrolysis steps elsewhere in lipid metabolism with base exchange. Common Pitfalls: Assuming that all head group transformations are hydrolytic or require water; conflating PS synthesis with phospholipase mediated hydrolysis. Final Answer: 0

Question 19

Subcellular location of fatty acid synthesis in eukaryotes  Where does de novo fatty acid synthesis (lipogenesis) primarily occur inside non-plant eukaryotic cells?

Accepted Answer

Introduction / Context: Fatty acid synthesis and fatty acid oxidation are spatially segregated in eukaryotic cells to enable reciprocal regulation. Identifying the correct compartment for de novo synthesis helps explain how metabolic pathways are coordinated and how malonyl CoA regulates mitochondrial fatty acid entry. Given Data / Assumptions: Non plant eukaryotes (e.g., animals) synthesize fatty acids predominantly in the cytosol. Key enzymes include acetyl CoA carboxylase (ACC) and fatty acid synthase (FAS). Plants additionally carry out synthesis in chloroplast stroma. Concept / Approach: Acetyl CoA generated in mitochondria is exported as citrate, which ATP citrate lyase converts back to cytosolic acetyl CoA. ACC produces malonyl CoA, and the multidomain FAS elongates the chain, using NADPH from the pentose phosphate pathway and malic enzyme. Malonyl CoA simultaneously inhibits carnitine palmitoyltransferase 1, preventing futile cycling with mitochondrial β oxidation. Step-by-Step Solution: Export carbon: citrate shuttle moves acetyl units to cytosol.Activate carbon: ACC forms malonyl CoA in cytosol.Elongate: FAS catalyzes iterative condensation/reduction/dehydration/reduction in cytosol.Coordinate: malonyl CoA inhibits CPT1 to favor synthesis over oxidation. Verification / Alternative check: Subcellular fractionation and immunolocalization place ACC and FAS in cytosol; pharmacologic inhibitors (e.g., TOFA) act on cytosolic enzymes, altering lipogenesis. Why Other Options Are Wrong: Mitochondrial matrix is the site of β oxidation, not synthesis. The plasma membrane and nucleus are not primary lipogenesis sites. ER participates in elongation/desaturation of products but is not the primary site of de novo synthesis initiation. Common Pitfalls: Assuming synthesis occurs where oxidation occurs or overlooking the role of citrate shuttle and cytosolic NADPH. Final Answer: Cytosol (with enzymes such as ACC and fatty acid synthase)

Question 20

Eukaryotic lipid metabolism — In which cellular compartment of eukaryotes does the bulk of fatty acid β-oxidation (fatty acid breakdown) occur before acetyl-CoA enters the TCA cycle?

Accepted Answer

Introduction: Understanding where fatty acids are catabolized inside eukaryotic cells is fundamental to biochemistry and physiology. This question targets the location of β-oxidation, the core pathway that converts long-chain fatty acids into acetyl-CoA for the citric acid (TCA) cycle and oxidative phosphorylation. Given Data / Assumptions: Eukaryotic cells possess mitochondria and, in many tissues, peroxisomes. β-oxidation sequentially removes two-carbon units as acetyl-CoA. Carnitine shuttles long-chain fatty acyl groups into mitochondria. Concept / Approach: The dominant site of fatty acid β-oxidation in eukaryotes is the mitochondrial matrix. Very-long-chain fatty acids (especially > C20) undergo initial chain-shortening in peroxisomes, but full energy extraction (NADH/FADH2 feeding the electron transport chain, and acetyl-CoA oxidation in the TCA cycle) relies on mitochondria. Thus, the most accurate general answer is the mitochondrial matrix. Step-by-Step Solution: 1) Activation: fatty acids → fatty acyl-CoA (cytosolic/outer mitochondrial membrane enzymes).2) Transport: carnitine shuttle transfers fatty acyl groups across the inner mitochondrial membrane.3) β-Oxidation proper: acyl-CoA dehydrogenase etc. operate in the mitochondrial matrix, producing acetyl-CoA, NADH, and FADH2.4) Energy harvest: acetyl-CoA enters the TCA cycle; reduced cofactors drive ATP synthesis in oxidative phosphorylation. Verification / Alternative check: Disorders of the carnitine shuttle or mitochondrial acyl-CoA dehydrogenases (e.g., MCAD deficiency) cause characteristic hypoketotic hypoglycemia, confirming the mitochondrial localization and physiological importance of matrix β-oxidation. Why Other Options Are Wrong: Cytosol: fatty acids are activated here, but β-oxidation occurs in mitochondria, not freely in cytosol. Plasma membrane: not a site of oxidative catabolism. ER lumen: involved in lipid synthesis and desaturation, not β-oxidation. Peroxisome only: peroxisomes shorten very-long chains and generate H2O2; complete energy extraction requires mitochondrial β-oxidation. Common Pitfalls: Overgeneralizing peroxisomal involvement. Remember: peroxisomes start the job for very-long chains; mitochondria finish it and make ATP. Final Answer: mitochondrial matrix.

Lipid Questions